Web Results

Sorafenib

en.wikipedia.org/wiki/Sorafenib

Sorafenib is a kinase inhibitor drug approved for the treatment of primary kidney cancer (advanced renal cell carcinoma), advanced primary liver cancer ...

Sorafenib: MedlinePlus Drug Information

medlineplus.gov/druginfo/meds/a607051.html

Aug 15, 2016 ... Sorafenib is used to treat advanced renal cell carcinoma (RCC; a type of cancer that begins in the kidneys). Sorafenib is also used to treat ...

Sorafenib (Nexavar) | Cancer Research UK

www.cancerresearchuk.org/about-cancer/cancers-in-general/treatment/cancer-drugs/sorafenib

Apr 29, 2015 ... Read about the cancer treatment drug sorafenib, otherwise known as Nexavar, including what it is, how it works and possible side effects.

FDA Approval for Sorafenib Tosylate - National Cancer Institute

www.cancer.gov/about-cancer/treatment/drugs/fda-sorafenib-tosylate

Nov 26, 2013 ... On November 22, 2013, the Food and Drug Administration (FDA) approved sorafenib tosylate (Nexavar<sup>®</sup> tablets, made by Bayer Healthcare ...

DrugBank: Sorafenib

www.drugbank.ca/drugs/DB00398

Jun 13, 2005 ... Sorafenib (rINN), marketed as Nexavar by Bayer, is a drug approved for the treatment of advanced renal cell carcinoma (primary kidney cancer) ...

Nexavar (Sorafenib): Side Effects, Interactions, Warning, Dosage ...

www.rxlist.com/nexavar-drug.htm

Learn about Nexavar (Sorafenib) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications.

sorafenib oral : Uses, Side Effects, Interactions, Pictures, Warnings ...

www.webmd.com/drugs/2/drug-94784/sorafenib-oral/details

Find patient medical information for sorafenib oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.

Sorafenib | C21H16ClF3N4O3 - PubChem

pubchem.ncbi.nlm.nih.gov/compound/Sorafenib

Sorafenib is a synthetic compound targeting growth signaling and angiogenesis. Sorafenib blocks the enzyme RAF kinase, a critical component of the ...

Sorafenib: a review of its use in advanced hepatocellular carcinoma.

www.ncbi.nlm.nih.gov/pubmed/19228077

Sorafenib (Nexavar) is an orally active multikinase inhibitor that is approved in the EU for the treatment of hepatocellular carcinoma. Monotherapy with sorafenib  ...

Sorafenib: Indications, Side Effects, Warnings - Drugs.com

www.drugs.com/cdi/sorafenib.html

Easy to read patient leaflet for sorafenib. Includes indications, proper use, special instructions, precautions, and possible side effects.

More Info

Sorafenib (Nexavar) Chemotherapy Drug Information - Chemocare

chemocare.com

Sorafenib (Nexavar) side effects, what it's used for, how it's given, how it works, drug type, precautions and self care tips.

Definition of sorafenib tosylate - NCI Drug Dictionary - National ...

www.cancer.gov

sorafenib tosylate: Patient Information: The tosylate salt of sorafenib, a synthetic compound targeting growth signaling and angiogenesis. Sorafenib blocks the ...

Nexavar - U.S. Food and Drug Administration

www.accessdata.fda.gov

NEXAVAR (sorafenib) tablets, oral. •. Hypertension: Monitor blood pressure weekly during the first 6 weeks. Initial U.S. Approval: 2005 and periodically thereafter ...